Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 21, 2006; 12(39): 6331-6338
Published online Oct 21, 2006. doi: 10.3748/wjg.v12.i39.6331
Published online Oct 21, 2006. doi: 10.3748/wjg.v12.i39.6331
Characteristic | DSRS (n = 40) | ES (n = 40) | P |
Age (yr) | 49.4 ± 9.9 | 53.8 ± 8.4 | 0.027 |
Sex: M/F | 27/13 | 33/7 | 0.121 |
Etiology: alcoholic/ non alcoholic | 14/26 | 26/14 | 0.0073 |
Child’s class: A/B | 19/21 | 11/29 | 0.053 |
Prothrombin time: > 80/80-50/< 50 | 5%/82%/13% | 13%/62%/25% | 0.058 |
Bilirubin (μmol/L): < 20.5/20.5-51.3/> 51.3 | 62%/38%/0% | 41%/46%/13% | 0.0269 |
Albumin (g/L): > 30/30-25/< 25 | 95%/5%/0% | 83%/17%/0% | 0.077 |
Portal perfusion: degree I/II/III | 45%/45%/10% | 42%/27%/31% | 0.09 |
Previous bleeding (n) | 2.3 ± 1.5 | 1.6 ± 0.09 | 0.022 |
Blood unit (n) | 5.5 ± 5 | 4.3 ± 4.2 | 0.25 |
Interval between bleeding and treatments (mo) | 3.5 ± 2.5 | 2.8 ± 3.2 | 0.32 |
Previous encephalopathy episodes (n) | 10 | 7 | 0.41 |
Easily controlled preoperative ascites | 5 | 11 | 0.09 |
- Citation: Santambrogio R, Opocher E, Costa M, Bruno S, Ceretti AP, Spina GP. Natural history of a randomized trial comparing distal spleno-renal shunt with endoscopic sclerotherapy in the prevention of variceal rebleeding: A lesson from the past. World J Gastroenterol 2006; 12(39): 6331-6338
- URL: https://www.wjgnet.com/1007-9327/full/v12/i39/6331.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i39.6331